ONEHEALTHDRUGS FOR ONE HEALTH DAY

Vector-borne parasitic diseases (VBPD) threaten the well-being and health of people and animals across the globe. Because human and veterinary drugs are pivotal in controlling these infections, its widespread use has unintentionally led to their release into the environment, with unpredictable detrimental effects on wildlife and ecosystems. To improve planetary safety and health, we recognise the urgent need for antiparasitic drugs that not only protect humans and animals but also safeguard our ecosystems. Through the EU COST-Action OneHealthdrugs, (CA21111) we are committed to innovate drug development, ensuring precise actions, for the early assessment of the drug environmental impact for optimal drug profiles.

To celebrate the One Health Day, we launch the international event, OneHealthdrugs Marathon that will take place on 20-23rd Nov.

With this event we would like:

  • to invite all network participants to share their research for the first time from the beginning of our Action and to increase our knowledge of the general research landscape existing in the network;
  • to attract external and applicant network participants
  • we also want to generate and transmit a positive feeling of open collaborative atmosphere;
  • we want to show how new concepts and innovative technologies can be integrated in perspective into all research programs  through collaboration, training schools and STSM-COST Action fellowships.

HG4 Young Investigator participation 22 November 2-6pm

Book of Abstract_OHD Marathon 2023

Program of The OHD marathon days

Summary of the OHD Marathon days

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi